The clinical effectiveness and cost effectiveness of routine anti-D prophylaxis for RhD-negative women in pregnancy

  • Technology appraisal guidance
  • TA41
  • Published: 

This guidance has been updated and replaced by NICE technology appraisal guidance 156.